CorrespondenceAntimyenteric neuronal antibodies and motility
References (10)
- et al.
Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement
Gastroenterology
(1997) - et al.
Autoantibody-associated sensory neuropathy and intestinal pseudo-obstruction without detectable neoplasia
Eur Neurol
(1996) - et al.
Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome
Neurology
(1993) - et al.
Antimyenteric neuronal antibodies in scleroderma
J Clin Invest
(1994) - et al.
A novel autoantibody exists in patients with esophageal achalasia
Gastroenterology
(1994)
Cited by (3)
Clinical aspects of neurointestinal disease: Pathophysiology, diagnosis, and treatment
2016, Developmental BiologyCitation Excerpt :A causal link between viral infections and neuropathological alterations has not been definitively demonstrated yet, although an increase in lymphocytic proliferation has been noted in esophageal biopsies of achalasic patients after exposure to herpes simplex 1, supporting a role for an immune response against viral agents infecting esophageal neurons in predisposed patients (Castagliuolo et al., 2004). Other studies have suggested that circulating autoantibodies might cause immune-mediated neuronal damage in patients with achalasia (Eaker, 1998; Verne et al., 1998), although the autoantibodies could certainly be the consequence of neuronal injury and the expression of normally occult neuronal antigens. Serum of achalasic patients has been shown to contain anti-neuronal antibodies that react against rodent enteric neurons (Latiano et al., 2006; Moses et al., 2003).
Review article: Molecular, pathological and therapeutic features of human enteric neuropathies
2008, Alimentary Pharmacology and TherapeuticsNeuropathy in the brain-in-the-gut
2000, European Journal of Gastroenterology and Hepatology